The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4Imprint Regulatory News (FOUR)

Share Price Information for 4Imprint (FOUR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6,080.00
Bid: 6,080.00
Ask: 6,120.00
Change: -180.00 (-2.88%)
Spread: 40.00 (0.658%)
Open: 6,370.00
High: 6,370.00
Low: 6,080.00
Prev. Close: 6,260.00
FOUR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Placing

28 Apr 2014 14:42

RNS Number : 6779F
4imprint Group PLC
28 April 2014
 

THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, TO RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL

 

 

28 April 2014

 

 

4imprint Group plc

 

("4imprint" or the "Company")

 

RESULT OF PLACING AND

NOTIFICATION OF TRANSACTIONS BY DIRECTORS

 

Further to the announcement made earlier on 28 April 2014 by the Company that four Directors and one senior employee intended to sell up to 1,000,000 Ordinary Shares, we can now confirm that 994,548 Ordinary Shares have been sold at a placing price of 630 pence per ordinary share.

 

Transactions by Directors

 

The Company was notified on 28 April 2014 of the following transactions by Directors of the Company pursuant to the 2011 Performance Share Plan.

 

Director

Options Exercised

Shares Sold

Resultant Holding

Resultant % Holding

John Poulter

300,000

210,000

120,000

0.429%

Gillian Davies

300,000

260,000

159,681

0.570%

Kevin Lyons-Tarr

300,000

150,000

249,432

0.891%

Andrew Scull

300,000

274,548

140,000

0.500%

 

 

Contacts:

 

4imprint Group plc +44 (0)20 7255 4800

John Poulter

Chairman

Espirito Santo Investment Bank +44 (0)20 7456 9191

John Dean

 

 

Execution Noble Limited (which conducts its UK investment banking business as Espirito Santo Investment Bank) ("Espirito Santo Investment Bank" or "BESI") is acting on the Placing and will not be responsible to anyone other than its clients for providing the protections afforded to its clients, nor for providing advice in relation to the Placing, the contents of this announcement, or any transaction or arrangement referred to herein.

 

This announcement is for information purposes only and does not constitute or form part of an offer or invitation to acquire or dispose of any securities of 4imprint, or constitute a solicitation of any offer to purchase or subscribe for securities in any jurisdiction, including the United States, Canada, Australia, Japan or The Republic of South Africa. 4imprint's shares have not been, and will not be, registered under the United States Securities Act of 1933, as amended, or under the securities legislation of any state of the United States and may not be offered or sold in the United States absent registration or an exemption from registration.

 

4imprint's shares may not, directly or indirectly, be offered or sold within the United States, Canada, Australia, Japan or The Republic of South Africa or offered or sold to a resident of Canada, Australia, Japan or The Republic of South Africa. No public offering of securities is being made in the United States.

 

This announcement is not for publication or distribution to persons in the United States of America, its territories or possessions or to any US person (within the meaning of Regulation S under the US Securities Act of 1933, as amended). Neither this announcement nor any copy of it may be taken or transmitted into Australia, Canada Japan or The Republic of South Africa or to Canadian persons or to any securities analyst or other person in any of those jurisdictions. Any failure to comply with this restriction may constitute a violation of United States, Australian, Canadian, Japanese or The Republic of South Africa securities law. The distribution of this announcement in certain other jurisdictions may be restricted by law and persons into whose possession this announcement comes should inform themselves about, and observe, any such restrictions.

 

This announcement and any offer of securities to which it relates are only addressed to and directed at persons who are (1) qualified investors within the meaning of directive 2003/71/EC and any relevant implementing measures (the prospectus directive) and (2) who have professional experience in matters relating to investments who fall within article 19(1) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order") or are persons falling within article 49(2)(a) to (d) ("High Net Worth Companies, Unincorporated Associations, etc") of the Order (all such persons together being referred to as "relevant persons"). The information regarding the Placing set out in this announcement must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this announcement relates is available only to relevant persons and will be engaged in only with relevant persons.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCXVLFLZZFZBBF
Date   Source Headline
2nd May 20249:19 amRNSHolding(s) in Company
16th Apr 202410:23 amRNSAnnual Financial Report
3rd Apr 20243:42 pmRNSDirector/PDMR Shareholding
28th Mar 20241:58 pmRNSDirector/PDMR Shareholding
28th Mar 20249:05 amRNSEBT Purchase
13th Mar 20247:00 amRNSFinal Results
28th Feb 20248:33 amRNSHolding(s) in Company
13th Feb 20244:49 pmRNSHolding(s) in Company
19th Jan 20247:00 amRNSTrading Statement
8th Jan 20248:27 amRNSBlock listing Interim Review
13th Dec 20238:52 amRNSCommittee changes
4th Dec 20231:23 pmRNSHolding(s) in Company
14th Nov 202312:28 pmRNSEBT Purchase
7th Nov 20237:00 amRNSTrading Statement
9th Oct 20238:17 amRNSEBT Purchase
21st Sep 20238:15 amRNSHolding(s) in Company
18th Aug 20238:09 amRNSDirectorate Change
1st Aug 20238:47 amRNSTrading Statement
31st Jul 20239:20 amRNSTotal Voting Rights
26th Jul 20233:23 pmRNSDirector/PDMR Shareholding
4th Jul 20237:00 amRNSPension Buy-in Transaction
29th Jun 20239:06 amRNSAdditional Listing
27th Jun 20239:41 amRNSBlock listing Interim Review
6th Jun 20231:36 pmRNSEBT Purchase
24th May 20232:12 pmRNSResult of AGM
24th May 20237:00 amRNSAGM Statement
12th May 20234:01 pmRNSHolding(s) in Company
17th Apr 20235:30 pmRNSAnnual Financial Report
14th Apr 20232:53 pmRNSHolding(s) in Company
29th Mar 20238:38 amRNSDirector/PDMR Shareholding
28th Mar 20238:04 amRNSEBT Purchase
15th Mar 20237:00 amRNSFinal Results
20th Jan 20237:00 amRNSTrading Statement
7th Dec 20223:38 pmRNSEBT Purchase
4th Nov 20227:00 amRNSTrading Statement
27th Oct 202212:42 pmRNSDirector Declaration
10th Oct 20229:01 amRNSEBT Purchase
16th Sep 20221:49 pmRNSHolding(s) in Company
12th Sep 20229:21 amRNSHolding(s) in Company
10th Aug 20227:00 amRNSHalf-year Report
2nd Aug 20229:13 amRNSHolding(s) in Company
1st Aug 20228:39 amRNSHolding(s) in Company
1st Aug 20228:00 amEQSBloc Ventures: Demand for deep tech unhindered by downturn
19th Jul 20227:00 amRNSTrading Statement
7th Jul 20222:26 pmRNSHolding(s) in Company
24th Jun 20229:37 amRNSEBT Purchase
6th Jun 20229:25 amRNSEBT Purchase
24th May 20221:18 pmRNSResult of AGM
24th May 20227:00 amRNSAGM Statement and Notice of Results
17th May 20227:35 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.